Eversept Partners, LP Cabaletta Bio, Inc. Transaction History

Eversept Partners, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Nov 08, 2023	SELL	$0.64 - $9.3 $177,658 - $2.58 Million	-277,592 Reduced 49.53%	282,874 $2.62 Million
Q4 2022 Feb 14, 2023	SELL	$0.64 - $9.3 $177,658 - $2.58 Million	-277,592 Reduced 49.53%	282,874 $2.62 Million
Q3 2022 Nov 08, 2023	BUY	$0.63 - $2.05 $353,093 - $1.15 Million	560,466 New	560,466 $353,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $2.05 $353,093 - $1.15 Million	560,466 New	560,466 $364,000
Q2 2021 Aug 16, 2021	SELL	$7.2 - $11.73 $553,312 - $901,438	-76,849 Closed	0 $0
Q1 2021 Nov 08, 2023	BUY	$10.39 - $14.53 $798,461 - $1.12 Million	76,849 New	76,849 $853,000
Q1 2021 May 13, 2021	BUY	$10.39 - $14.53 $798,461 - $1.12 Million	76,849 New	76,849 $853,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $76M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.